Spero Therapeutics Inc Financial Flexibility Index
Spero Therapeutics Inc financial flexibility index. Spero Therapeutics Inc (SPRO) has a Financial Flexibility Index of -0.84x as of December 2025. Free cash flow of $-8.35 Million (operating CF $-8.35 Million minus capex $0.00) represents -1% of total liabilities ($9.90 Million). See SPRO free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Spero Therapeutics Inc (2015–2025)
Financial flexibility index of Spero Therapeutics Inc from 2015 to 2025. Historical Financial Flexibility Index trend for Spero Therapeutics Inc across 11 annual periods. Check SPRO cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Spero Therapeutics Inc Financial Flexibility Index by Year (2015–2025)
Spero Therapeutics Inc financial flexibility index by year from 2015 to 2025. Year-by-year free cash flow to debt coverage for Spero Therapeutics Inc. For the full cash flow conversion analysis, see SPRO cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.28x | $-12.62 Million | $-12.62 Million | $9.90 Million | ▼ -250.5% |
| 2024 | -0.36x | $-23.44 Million | $-23.44 Million | $64.42 Million | ▲ +16.7% |
| 2023 | -0.44x | $-32.99 Million | $-32.99 Million | $75.50 Million | ▼ -176.3% |
| 2022 | -0.16x | $-7.73 Million | $-7.73 Million | $48.87 Million | — |
| 2021 | 0.00x | $0.00 | $-64.35 Million | $82.78 Million | ▲ +100.0% |
| 2020 | -4.00x | $-85.72 Million | $-85.87 Million | $21.41 Million | ▼ -153.9% |
| 2019 | -1.58x | $-49.71 Million | $-50.02 Million | $31.53 Million | ▲ +44.3% |
| 2018 | -2.83x | $-37.19 Million | $-39.62 Million | $13.15 Million | ▲ +38.3% |
| 2017 | -4.59x | $-39.08 Million | $-39.11 Million | $8.52 Million | ▼ -20.8% |
| 2016 | -3.80x | $-28.13 Million | $-28.96 Million | $7.41 Million | ▼ -200.9% |
| 2015 | -1.26x | $-9.38 Million | $-9.61 Million | $7.43 Million | — |